#Esketamine Drug For #Depression Treatment Nears FDA Approval - Bloomberg
▻https://www.bloomberg.com/news/articles/2019-02-12/first-big-depression-advance-since-prozac-nears-fda-approval
Johnson & Johnson’s esketamine, a close chemical cousin of the anesthetic #ketamine, cleared a major hurdle on Tuesday when a panel of outside experts recommended that the FDA approve the treatment. The fast-acting antidepressant, administered via a nasal spray, is being tested in major depressive disorder and suicidal thinking. If approved, it would be the first major therapeutic advance for depression since the introduction of Prozac in 1987